Back
Teva Pharmaceutical Industries 10K Form
Sell
42
TEVA
Teva Pharmaceutical Industries
Last Price:
12.86
Seasonality Move:
0.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-02-12 | 10K | TEVA/Teva Pharmaceutical Industries Annual |
| 2023-11-09 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-08-02 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-05-10 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
| 2023-02-10 | 10K | TEVA/Teva Pharmaceutical Industries Annual |
| 2022-11-03 | 10Q | TEVA/Teva Pharmaceutical Industries Quarterly |
Receive TEVA News And Ratings
See the #1 stock for the next 7 days that we like better than TEVA
TEVA Financial Statistics
Sales & Book Value
| Annual Sales: | $15.85B |
|---|---|
| Cash Flow: | $1.07B |
| Price / Cash Flow: | 17.03 |
| Annual Sales: | $6.70 |
| Price / Book: | 1.91 |
Profitability
| EPS (TTM): | -0.47000 |
|---|---|
| Net Income (TTM): | $-559M |
| Gross Margin: | $7.65B |
| Return on Equity: | -6.89% |
| Return on Assets: | -1.29% |
Teva Pharmaceutical Industries Earnings Forecast
Key Teva Pharmaceutical Industries Financial Ratios
- The Gross Profit Margin over the past 38 years for TEVA is 48.25%.
- The Selling, General & Administrative Expenses for TEVA have been equal to 22.08% of Gross Profit Margin.
- The Research & Development expenses have been 6.01% of Revenue.
- The Interest Expense is -184.08% of Operating Income.
- The Net Earning history of TEVA is -3.53% of Total Revenues.
- Per Share Earnings over the last 38 years have been positive in 21 years.
Teva Pharmaceutical Industries Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TEVA |
| CUSIP: | 881624 |
| Website: | tevapharm.com |
Debt
| Debt-to-Equity Ratio: | 2.64 |
|---|---|
| Current Ratio: | 1.02 |
| Quick Ratio: | 0.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 4.84 |
TEVA Technical Analysis vs Fundamental Analysis
Sell
42
Teva Pharmaceutical Industries (TEVA)
is a Sell
Is Teva Pharmaceutical Industries a Buy or a Sell?
-
Teva Pharmaceutical Industries stock is rated a Sell
The current Teva Pharmaceutical Industries [TEVA] share price is $12.78. The Score for TEVA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.